Maylan Laboratories Limited (full cycle manufacturing of medicinal product including production, packaging, labelling, quality control and stability testing, batch release)
UkraineAll drugs from this manufacturer
-
The drug is indicated as part of combination therapy for the treatment of HIV-1-infected adults, as well as adolescents aged 12 to 18 years, if there are contraindications to the use of first-line drugs.
Dosage form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir disoproxil fumarate 300 mg ATC: J05AR03